Clinical Trial: The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title:

Brief Summary: The investigators are studying the impact of RPh201 on chronic vegetative patients. RPh201 has been reported to induce neuronal regeneration in animal models. Evaluation will be done by combining clinical /behavioral assessment with fMRI studies.

Detailed Summary:
Sponsor: Hadassah Medical Organization

Current Primary Outcome: change in the awareness status of the patients. [ Time Frame: 3-6 months ]

Clinical and laboratory assessment will be done every two weeks along the treatment period fMRI assessment will be performed 3 times: before the treatment, immediate afterwards and one month following treatment cessation.


Original Primary Outcome: Same as current

Current Secondary Outcome: change in the awareness status of the patients. [ Time Frame: 1 month following the end of the trial ]

clinical and fMRI assessment will be performed 1 month following treatment cessation


Original Secondary Outcome: Same as current

Information By: Hadassah Medical Organization

Dates:
Date Received: August 15, 2011
Date Started: October 2011
Date Completion: October 2018
Last Updated: September 20, 2015
Last Verified: August 2011